Deliberate total parathyroidectomy: A potentially novel therapy for tumor-induced hypophosphatemic osteomalacia

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages 4273-4278

  Bhadada, Sanjay K ^b   Palnitkar, Saroj ^a   Qiu, Shijing ^a   Parikh, Nayana ^a   Talpos, Gary B ^a   Rao, Sudhaker D ^a  

^a HENRY FORD HOSPITAL   (United States)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE;

ADULT; CALCIUM BLOOD LEVEL; CASE REPORT; CONFERENCE PAPER; DRUG DOSE REDUCTION; FIBROBLAST GROWTH FACTOR 23 BLOOD LEVEL; FOLLOW UP; HEALING; HUMAN; HYPERCALCEMIA; HYPERCALCEMIC HYPERPARATHYROIDISM; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; LABORATORY TEST; LOW DRUG DOSE; MALE; ONCOGENIC OSTEOMALACIA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REFERENCE VALUE; SYMPTOM; TREATMENT RESPONSE;

BONE NEOPLASMS; HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; OSTEOMALACIA; PARATHYROID GLANDS; PARATHYROIDECTOMY; TREATMENT OUTCOME;

EID: 84887485721     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2705     Document Type: Conference Paper

References (26)

1. Fukumoto S, Yamashita T. Fibroblast growth factor (FGF)-23 and hypophosphatemic rickets/osteomalacia. Endocr J. 2001;48: 603-610.
2. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 1991;325: 1843-1848.
3. Haeusler G, Freilinger M, Dominkus M, et al. Tumor-induced hypophosphatemic rickets in an adolescent boy - clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue. J Clin Endocrinol Metab. 2010;95: 4511-4517.
4. White KE, Larsson TE, Econs MJ. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev. 2006;27: 221-241.
5. Tenenhouse HS. Phosphate transport: molecular basis, regulation and pathophysiology. J Steroid Biochem Mol Biol. 2007;103: 572-577.
6. Barthel TK, Mathern DR, Whitfield GK, et al. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J Steroid Biochem Mol Biol. 2007;103: 381-388.
7. Sommer S, Berndt T, Craig T, Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol. 2007;103: 497-503.
8. Ruppe MD, Jan De beur SM. Disorders of phosphate homeostasis. In: Rosen CJ, Compston JE, Lian JB, eds. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7th ed. Washington, DC:American Society for Bone and Mineral Research; 2009: 317-325.
9. Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium- 111 octreotide scintigraphy. Clin Endocrinol (Oxf). 2001;54: 551-554.
10. Leaf DE, Pereira RC, Bazari H, Juppner H. Oncogenic osteomalacia due toFGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab. 2013;98: 887-891.
11. Rasmussen H, Tenenhouse HS. Hypophosphatemias. In: Scriver CR, Beaudet AC, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 6th ed. New York, NY: McGraw-Hill; 1989: 2581-2604.
12. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26: 1381-1388.
13. Bertocchini A, Falappa P, Accinni A, Devito R, Inserra A. Radiofrequency thermoablation in chest wall mesenchymal hamartoma of an infant. Ann Thorac Surg. 2007;84: 2091-2093.
14. Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT.Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res. 2007;22: 931-937.
15. EdelsonGW,ShihMS,ParfittAM.Aunique case of adult hypophosphatemic osteomalacia. Bone. 1993;14: 707-710.
16. Huang QL, Feig DS, Blackstein ME. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia. J Endocrinol Invest. 2000;23: 263-267.
17. Sudhaker Rao D, Han ZH, Phillips ER, Palnitkar S, Parfitt AM. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol (Oxf). 2000;53: 373-381.
18. Riggs BL, Sprague RG, Jowsey J, Maher FT. Adult-onset vitamin- D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy. N Engl J Med. 1969;281: 762-766.
19. Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD. Tertiary hyperparathyroidism during high phosphate therapy of familia hypophosphatemic rickets. J Clin Endocrinol Metab. 1992;75:1514- 1518.
20. Parfitt AM. Regulation or permission? J Bone Miner Res. 2006;21: 659-660.
21. Chong WH, Yavuz S, Patel SM, Chen CC, Collins MT. The importance of whole body imaging in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2011;96: 3599-3600.
22. Bergwitz C, Collins MT, Kamath RS, Rosenberg AE. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-yearold man with hypophosphatemia. N Engl J Med. 2011;365:1625- 1635.
23. Firth RG, Grant CS, Riggs BL. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases. Am J Med. 1985;78: 669-673.
24. Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res. 1996;11: 1967-1975.
25. Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res. 1997;12: 498-508.
26. Parfitt AM, Han ZH, Palnitkar S, Rao DS, Shih MS, Nelson D. Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res. 1997;12: 1864-1873.